Skip to main content
icon for ¿Casos de sarampión en EE. UU. antes del 30 de abril?

¿Casos de sarampión en EE. UU. antes del 30 de abril?

icon for ¿Casos de sarampión en EE. UU. antes del 30 de abril?

¿Casos de sarampión en EE. UU. antes del 30 de abril?

abr 30

may 31

dic 31

abr 30

may 31

dic 31

$485,371 Vol.

30 abr 2026
Polymarket

$485,371 Vol.

Polymarket

1800

$171,324 Vol.

1%

1900

$75,376 Vol.

1%

1850

$28,275 Vol.

2%

2000

$57,937 Vol.

<1%

1,950

$35,959 Vol.

1%

2100

$16,839 Vol.

<1%

2200

$38,552 Vol.

<1%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.CDC reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated and 92% among unvaccinated or unknown-status individuals, driving trader consensus on a total near 1,800 by month-end. Weekly incidence by rash onset has slowed markedly—from 112 cases in early March to just seven the week of April 19—following South Carolina's record outbreak declaration and containment efforts, though Utah (425+ cases), Texas, and Florida sustain transmission in under-vaccinated communities. Hospitalizations stand at 6%, with no deaths. Reporting lags create uncertainty for the April 30 cutoff; traders await potential CDC updates resolving to the official 2026 case counter, amid warnings of travel-related importations.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$485,371
Fecha de finalización
30 abr 2026
Mercado abierto
Apr 14, 2026, 9:30 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.CDC reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated and 92% among unvaccinated or unknown-status individuals, driving trader consensus on a total near 1,800 by month-end. Weekly incidence by rash onset has slowed markedly—from 112 cases in early March to just seven the week of April 19—following South Carolina's record outbreak declaration and containment efforts, though Utah (425+ cases), Texas, and Florida sustain transmission in under-vaccinated communities. Hospitalizations stand at 6%, with no deaths. Reporting lags create uncertainty for the April 30 cutoff; traders await potential CDC updates resolving to the official 2026 case counter, amid warnings of travel-related importations.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$485,371
Fecha de finalización
30 abr 2026
Mercado abierto
Apr 14, 2026, 9:30 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. antes del 30 de abril?" es un mercado de predicción en Polymarket con 9 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "1750" con 100%, seguido de "1775" con 100%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 100¢ implica que el mercado colectivamente asigna una probabilidad de 100% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "¿Casos de sarampión en EE. UU. antes del 30 de abril?" ha generado $485.4K en volumen total de trading desde que el mercado se lanzó el Mar 24, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "¿Casos de sarampión en EE. UU. antes del 30 de abril?", explora los 9 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" es "1750" con 100%, lo que significa que el mercado asigna una probabilidad de 100% a ese resultado. El siguiente resultado más cercano es "1775" con 100%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.